Granted Patent
B2
US 11,873,310 · App. 17/395,723 · Granted Jan 16, 2024
Compounds useful in HIV therapy
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The invention relates to compounds of Formula (I), (Ia), (Ib), (II) or (III), salts thereof, pharmaceutical compositions thereof, as well as therapeutic methods of treatment and prevention.
Claims (5)
1. A compound of the formula:
or a pharmaceutically acceptable salt thereof.
2. A pharmaceutical composition comprising a compound according to claim 1 or pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable excipient.
3. A compound of the formula:
4. A pharmaceutical composition comprising a compound according to claim 3 , and a pharmaceutically acceptable excipient.
Assignments (3)
CHANGE OF ADDRESS
Recorded Oct 8, 2025
From: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
Reel/Frame 073032/0390 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Aug 18, 2022
From: DE LA ROSA, MARTHA ALICIA; TAI, VINCENT WING-FAI; TANG, JUN; DUNHAM, RICHARD M.
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED; VIIV HEALTHCARE COMPANY
Reel/Frame 060842/0281 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Aug 18, 2022
From: MARGOLIS, DAVID
To: THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL
Reel/Frame 060842/0363 →
Continuity (5)
Continuation
16621312
Provisional Application
62773563
· Nov 30, 2018